CHOP and the endoplasmic reticulum stress response in myelinating glia

Current Opinion in Neurobiology

Volumn 19, Issue 5, 2009, Pages 505-510

  Gow, Alexander ^a   Wrabetz, Lawrence ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PROTEOLIPID PROTEIN;

APOPTOSIS; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE EXACERBATION; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GENE MUTATION; GLIA; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMMUNOPATHOGENESIS; METABOLIC STRESS; MULTIPLE SCLEROSIS; MYELINATED NERVE; NEGATIVE FEEDBACK; NERVE CELL DIFFERENTIATION; NERVE CELL LESION; NERVE CELL NECROSIS; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; REVIEW; SCHWANN CELL; WHITE MATTER;

ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM; MODELS, NEUROLOGICAL; MYELIN SHEATH; NEUROGLIA; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTOR CHOP;

EID: 70450214826     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2009.08.007     Document Type: Review

References (32)

1. Ron D., and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8 (2007) 519-529
2. Rutkowski D.T., and Kaufman R.J. That which does not kill me makes me stronger: adapting to chronic ER stress. Trends Biochem Sci 32 (2007) 469-476
3. Pavitt G.D. eIF2B, a mediator of general and gene-specific translational control. Biochem Soc Trans 33 (2005) 1487-1492
4. Lin W., Harding H.P., Ron D., and Popko B. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 169 (2005) 603-612
5. Southwood C.M., Garbern J., Jiang W., and Gow A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36 (2002) 585-596
6. Pennuto M., Tinelli E., Malaguti M., Del Carro U., D'Antonio M., Ron D., Quattrini A., Feltri M.L., and Wrabetz L. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 57 (2008) 393-405. This paper reports induction of the UPR in CMT1B neuropathy for the first time and demonstrates genetically that CHOP expression is maladaptive, but causes Schwann cell dysfunction (demyelination) not cell death.
7. Lin W., and Popko B. Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 12 (2009) 379-385
8. Duncan I.D. Dissection of the phenotype and genotype of the X-linked myelin mutants. In: Duncan I.D., Skoff R.P., and Colman D.R. (Eds). Myelination and Dysmyelination vol. 605 (1990), New York Academy of Sciences 110-121
9. Gow A. Protein misfolding as a disease determinant. In: Lazzarini R.A. (Ed). Myelin Biology and Disorders vol. 1 (2004), Elsevier 877-885
10. Gow A., Southwood C.M., and Lazzarini R.A. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J. Cell. Biol. 140 (1998) 925-934
11. Gow A., Friedrich V.L., and Lazzarini R.A. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res. 37 (1994) 574-583
12. Southwood C.M., and Gow A. Molecular mechanisms of disease stemming from mutations in the proteolipid protein gene. Micros. Res. Tech. 52 (2001) 700-708
13. Sharma R., and Gow A. Minimal role for caspase 12 in the unfolded protein response in oligodendrocytes in vivo. J Neurochem 101 (2007) 889-897. Although caspase 12 expression is induced at the levels of mRNA and protein in Plp1 mutant mice, its absence does not alter the levels of apoptosis occurring in response to metabolic stress. Thus, caspase 12 is not an obligatory UPR caspase in vivo.
14. Swanton E., High S., and Woodman P. Role of calnexin in the glycan-independent quality control of proteolipid protein. EMBO J 22 (2003) 2948-2958
15. Sharma R., Jiang H., Zhong L., Tseng J., and Gow A. Minimal role for activating transcription factor 3 in the oligodendrocyte unfolded protein response in vivo. J Neurochem 102 (2007) 1702-1713
16. Trapp B.D., and Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 31 (2008) 247-269
17. Lin W., Bailey S.L., Ho H., Harding H.P., Ron D., Miller S.D., and Popko B. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest 117 (2007) 448-456. This paper provides further evidence that the PERK pathway is adaptive in oligodendrocytes in a variety of normal and pathological contexts. In this case, cytokine activation of PERK before onset of experimental allergic encephalitis in mice, a model of MS, is protective and has therapeutic implications.
18. Lin W., Kunkler P.E., Harding H.P., Ron D., Kraig R.P., and Popko B. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am J Pathol 173 (2008) 1508-1517. Popko and colleagues provide evidence that genetic or pharmacological inhibition of GADD34 and its reversal of eIF2alpha phosphorylation is adaptive in myelinating oligodendrocytes challenged by IFNγ, consistent with the idea that PERK activation is adaptive, and GADD34 activation is maladaptive in oligodendrocytes.
19. Fogli A., and Boespflug-Tanguy O. The large spectrum of eIF2B-related diseases. Biochem Soc Trans 34 (2006) 22-29
20. van Kollenburg B., van Dijk J., Garbern J., Thomas A.A., Scheper G.C., Powers J.M., and van der Knaap M.S. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol 65 (2006) 707-715
21. Kantor L., Pinchasi D., Mintz M., Hathout Y., Vanderver A., and Elroy-Stein O. A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells. PLoS One 3 (2008) e3783
22. Dietrich J., Lacagnina M., Gass D., Richfield E., Mayer-Proschel M., Noble M., Torres C., and Proschel C. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med 11 (2005) 277-283
23. Scherer S.S., and Wrabetz L. Molecular mechanisms of inherited demyelinating neuropathies. Glia 56 (2008) 1578-1589
24. D'Antonio M., Feltri M.L., and Wrabetz L. Myelin under stress. J Neurosci Res (2009) 10.1002/jnr.22066
25. Wrabetz L., D'Antonio M., Pennuto M., Dati G., Tinelli E., Fratta P., Previtali S., Imperiale D., Zielasek J., Toyka K., et al. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci 26 (2006) 2358-2368
26. Martini R., Zielasek J., Toyka K., Giese K., and Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves charastic of inherited human neuropathies. Nat Genet 11 (1995) 281-286
27. Lin J.H., Li H., Zhang Y., Ron D., and Walter P. Divergent effects of PERK and IRE1 signaling on cell viability. PLoS One 4 (2009) e4170. This study employs ingenious extended, single activation of PERK or IRE1 (uncoupled from protein misfolding) in cultured cells to demonstrate that the quantitative balance between PERK and IRE1 signals may determine death versus survival fates, respectively.
28. Marciniak S.J., Yun C.Y., Oyadomari S., Novoa I., Zhang Y., Jungreis R., Nagata K., Harding H.P., and Ron D. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18 (2004) 3066-3077
29. Tsang K.Y., Chan D., Cheslett D., Chan W.C., So C.L., Melhado I.G., Chan T.W., Kwan K.M., Hunziker E.B., Yamada Y., et al. Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol 5 (2007) e44. One of the first examples of incomplete differentiation/dedifferentiation occurring in response to a UPR in the absence of apoptosis. This study raises the possibility that some cell types can ameliorate maladaptive effects of UPR signaling by dedifferentiating.
30. Parkinson D.B., Bhaskaran A., Arthur-Farraj P., Noon L.A., Woodhoo A., Lloyd A.C., Feltri M.L., Wrabetz L., Behrens A., Mirsky R., et al. c-Jun is a negative regulator of myelination. J Cell Biol 181 (2008) 625-637. This paper shows that Krox 20 and c-Jun have a reciprocally antagonistic function and regulation during development; c-Jun is predominant as part of an active program of dedifferentiation of Schwann cells.
31. Gardinier M.V., and Macklin W.B. Myelin proteolipid protein gene expression in jimpy and jimpy(msd) mice. J Neurochem 51 (1988) 360-369
32. Franklin R.J., and Goldman J.E. Remyelination by endogenous glia. In: Lazzarini R.A. (Ed). Myelin Biology and Disorders vol. 1 (2004), Elsevier Academic Press 173-196